Evolution of genetic markers for drug resistance after the introduction of dihydroartemisinin–piperaquine as first-line anti-malarial treatment for uncomplicated falciparum malaria in Indonesia

Míreanna comhchosúla

• Evolution of genetic markers for drug resistance after the introduction of dihydroartemisinin–piperaquine as first-line anti-malarial treatment for uncomplicated falciparum malaria in Indonesia
  de réir: Farindira Vesti Rahmasari, et al.
  Foilsithe / Cruthaithe: (2023-08-01)
• Drug resistance of Plasmodium falciparum and Plasmodium vivax isolates in Indonesia
  de réir: Rahmasari, FV, et al.
  Foilsithe / Cruthaithe: (2022)
• Efficacy and safety of dihydroartemisinin–piperaquine for the treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax malaria in Papua and Sumatra, Indonesia
  de réir: Puji B. S. Asih, et al.
  Foilsithe / Cruthaithe: (2022-03-01)
• Efficacy and safety of dihydroartemisinin-piperaquine.
  de réir: Myint, H, et al.
  Foilsithe / Cruthaithe: (2007)
• Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial.
  de réir: Awab, G, et al.
  Foilsithe / Cruthaithe: (2010)